– Interview with John McDonald, Ph.D., Professor and Chair of the School of Biology at Georgia Tech and Chief Research Scientist at the Ovarian Cancer Institute

PodcastsResourcesCancersGynecologic cancerMedicine, Diagnosis, and TherapeuticsNanoparticlesNanotechnologyOvarian cancerSystemic conditionsTechnology and Computational Biology
Previous articleGenentech Believes that It Is Worth More than the $43.7B Roche Is Offering
Next articleTGen to Assess febit’s DNA Capture Method in Next-Generation Sequencing Efforts